Healthcare Asia Magazine on MSN
Agilent and Singapore’s NATI sign research partnership on oligonucleotide therapeutics
The work focuses on oligonucleotide therapeutics. Agilent Technologies Inc. has signed a two-year research collaboration ...
Agilent Technologies Inc. (NYSE: A) today announced a two-year research collaboration agreement with Singapore's Nucleic Acid Therapeutics Initiative (NATi), hosted by Agency for Science, Technology ...
‡ Chromaleont s.r.l. A Start-Up of the University of Messina, c/o University of Messina, Via Álvaro del Portillo, 21, 98168 Messina, Italy § Centro Integrato di Ricerca (CIR), Università Campus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results